Shionogi Articles
Stock Commentary Tokyo
4 November 1999
Stock Commentary Tokyo
14 October 1999
Japan's drugmakers will have to "globalize"
10 September 1999
Stock Commentary Tokyo
24 June 1999
Positive 1st-qtr news from AstraZeneca
26 May 1999
Strong net profits growth for Sankyo
24 May 1999
Stock Commentary Tokyo
20 May 1999
AstraZeneca rated outperform by MSDW
19 April 1999
Stock Commentary Tokyo
31 March 1999
Stock Commentary Tokyo
18 March 1999
Stock Commentary Tokyo
11 March 1999
Stock Commentary Tokyo
4 March 1999
Zeneca invests in "superstatin" facility
16 February 1999
Zeneca fast-tracks ZD4522 "superstatin"
15 February 1999
Stock Commentary Tokyo
17 December 1998
AstraZeneca's Effect On Rest Of Pharma Sector
17 December 1998
Astra & Zeneca Join In Euro Merger Mania
10 December 1998
Astra & Zeneca Join In Euro Merger Mania
9 December 1998
Merger And Acquisition Prospects In Japan
7 December 1998
Shionogi Reorganizes R&D Systems
24 November 1998
B-MS To Take Up To $500M 4th-Qtr Charge
18 November 1998
Japanese Firms Report Disappointing Figures
18 November 1998
Mundipharma Sets Up Japanese Branch
2 November 1998
New Antibacterials Showcased At ICAAC
14 October 1998
Zeneca Updates Its R&D Pipeline
6 August 1998
Stock Commentary Tokyo
23 July 1998
Multinationals In Japan Slim Down Faster Than Locals
14 July 1998
Shionogi buys plant
2 July 1998
Agouron Shopping For HIV Portfolio
1 July 1998
Stock Commentary Tokyo
25 June 1998
Zeneca Licenses "SuperStatin"
22 April 1998
1997: Another Good Year For New Chemical Entities
6 January 1998
Stock Commentary Tokyo
18 December 1997
Shionogi To Merge Wholesale Affiliates
18 December 1997
Japanese Wholesaler Consolidation - The Reality
5 September 1997
Steady Progress At Shionogi At Year-End
30 May 1997
New CPAC Approvals Include Two NCEs
7 April 1997
TOKYO STOCK COMMENT
10 March 1997
Moody's Rates Japan Companies Facing Drug Spending Curbs
24 February 1997
Shionogi Licenses Japanese Rights To MARNAC's Pirfenidone
24 February 1997
TOKYO STOCK COMMENT
10 February 1997
TOKYO STOCK COMMENT
3 February 1997
Asta Medica Takes Over Europeptides
6 January 1997
Stock Spectrum
9 December 1996
Sales And Earnings -Million Yen
2 December 1996
Interim Profits At Shionogi And Green Cross Hit
2 December 1996
3% Japanese NHI Price Cuts Forecast For April
21 October 1996
Tokyo Stock Comment
9 September 1996
Scios Launch CHF Blood Test In Japan
2 September 1996
Asta's Cetrorelix Enters Phase III Trials; NCE Update
12 August 1996
Irbesartan In Japan
27 May 1996
Tokyo Stock Comment
27 May 1996
US And Japanese Firms Hold Most DNA Sequences
15 April 1996
TOKYO STOCK COMMENT
29 January 1996
NCEs In 1995: A Good Range Of Novel Drugs
29 January 1996
Tokyo Stock Comment
22 January 1996
Tokyo Stock Comment
8 January 1996
Mixed Interims From Japanese Drug Majors
20 November 1995
Forecast Changes By Japan Company Handbook
6 November 1995
TOKYO STOCK COMMENT
17 July 1995
Four Japanese companys launch high-dose morphine
10 July 1995
TOKYO STOCK COMMENT
3 July 1995
Schering-Plough Is "Right-Sized And Flexible"
3 July 1995
TOKYO STOCK COMMENT
26 June 1995
Asta Medica And Nippon Kayaku JV
26 June 1995
Japanese Cos Post Unconsolidated Results
5 June 1995
Tokyo STOCK COMMENT
24 April 1995
Tokyo Stock Comment
17 April 1995
Imizadole Animal Studies
17 April 1995
Tokyo Stock Comment
3 April 1995
R&D Spending Reduced By Some Japanese Firms
13 March 1995
Japanese Drugmakers "Are Least Profitable"
27 February 1995
Tokyo Stock Comment
6 February 1995
Tokyo Stock Comment
9 January 1995
Shionogi Posts Good Interim Sales
5 December 1994
Tokyo Stock Comment
28 November 1994
TOKYO STOCK COMMENT
7 November 1994
Glaxo Leads Pharma World League, Says DDT
17 October 1994
New Japanese NDAs Filed
5 September 1994
Tokyo Stock Comment
18 July 1994
JAPANESE HEALTH LEGISLATION MOVES
4 July 1994
TOKYO STOCK COMMENT
27 June 1994
BIOPHARMA GROWTH MARKETS OF THE FUTURE
27 June 1994
TOKYO STOCK COMMENT
20 June 1994
TOKYO STOCK COMMENT
13 June 1994
BIOPHARMACEUTICALS MARKET GROWING FAST
13 June 1994
SHIONOGI'S PROFITS RISE WHILE SALES FALL
30 May 1994
TOKYO STOCK COMMENT
18 April 1994
JAPANESE DRUG PRICE CUTS SURVEY
18 April 1994
TOKYO STOCK COMMENT
11 April 1994
NHI CUTS IMPACT ON DRUG CO'S REVENUES
4 April 1994
STEADY SALES GROWTH FOR CHUGAI PHARMA
7 March 1994
TOKYO STOCK COMMENT
28 February 1994
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
